I. Physical examination characteristics
|
1. No lymph node metastasis |
2. No fixation |
3. No voice abnormalities |
4. No vocal cord paralysis |
II. Ultrasound characteristics (see also Table
2) |
1. Low and intermediate nodule findings: isoechoic or hypoechoic, oval to round, sharp regular margin, hypoechoic rim |
2. Not taller than wide |
3. No microcalcifications |
4. No contralateral lobe nodules |
5. No extrathyroidal extension |
6. No posterior abutment |
7. No lymph node metastasis |
8. No fixation |
9. No vocal cord paralysis |
III. Cytology characteristics (see also Table
1) |
Bethesda III, IV, or V with: |
+ Follicular pattern |
+ Hypercellular |
+ Microfollicular architecture |
+ Sheet‐like architecture |
‐ No papillae |
‐ No psammomatous calcifications |
‐ No prominent nuclear pseudoinclusions |
‐ No prominent nuclear grooves |
‐ No necrosis or mitoses |
IV. Molecular characteristics
|
1. May have RAS, THADA fusion, or PAX8‐PARG |
2. Should not have BRAF, RET fusion, TERT promoter, or other high‐grade mutation |
V. Patient/endocrine characteristics
|
1. Willing to have second surgery if needed |
2. Medically fit for possible second anesthesia |
3. Endocrinologist in agreement with initial lobectomy surgery |